Literature DB >> 18473170

Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation.

Claudia Piccoli1, Annamaria Sardanelli, Rosella Scrima, Maria Ripoli, Giovanni Quarato, Annamaria D'Aprile, Francesco Bellomo, Salvatore Scacco, Giuseppe De Michele, Alessandro Filla, Arcangela Iuso, Domenico Boffoli, Nazzareno Capitanio, Sergio Papa.   

Abstract

In the present study mitochondrial respiratory function of fibroblasts from a patient affected by early-onset parkinsonism carrying the homozygous W437X nonsense mutation in the PINK1 gene has been thoroughly characterized. When compared with normal fibroblasts, the patient's fibroblast mitochondria exhibited a lower respiratory activity and a decreased respiratory control ratio with cellular ATP supply relying mainly on enhanced glycolytic production. The quantity, specific activity and subunit pattern of the oxidative phosphorylation complexes were normal. However, a significant decrease of the cellular cytochrome c content was observed and this correlated with a reduced cytochrome c oxidase in situ-activity. Measurement of ROS revealed in mitochondria of the patient's fibroblasts enhanced O(2)(*-) and H(2)O(2) production abrogated by inhibition of complex I. No change in the glutathione-based redox buffering was, however, observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473170     DOI: 10.1007/s11064-008-9729-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP.

Authors:  Nae-Cherng Yang; Wai-Meng Ho; Yu-Hsuan Chen; Miao-Lin Hu
Journal:  Anal Biochem       Date:  2002-07-15       Impact factor: 3.365

2.  Cooperative proton-transfer reactions in the respiratory chain: redox bohr effects.

Authors:  S Papa; F Guerrieri; G Izzo
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 3.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

4.  Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

Authors:  Hans-Hermann Hoepken; Suzana Gispert; Blas Morales; Oliver Wingerter; Domenico Del Turco; Alexander Mülsch; Robert L Nussbaum; Klaus Müller; Stefan Dröse; Ulrich Brandt; Thomas Deller; Brunhilde Wirth; Alexei P Kudin; Wolfram S Kunz; Georg Auburger
Journal:  Neurobiol Dis       Date:  2006-11-30       Impact factor: 5.996

5.  Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols.

Authors:  David K Johnson; Kurt J Schillinger; David M Kwait; Chambers V Hughes; Erin J McNamara; Fauod Ishmael; Robert W O'Donnell; Ming-Mei Chang; Michael G Hogg; Jonathan S Dordick; Lakshmi Santhanam; Linda M Ziegler; James A Holland
Journal:  Endothelium       Date:  2002

6.  Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I.

Authors:  Arcangela Iuso; Salvatore Scacco; Claudia Piccoli; Francesco Bellomo; Vittoria Petruzzella; Raffaella Trentadue; Michele Minuto; Maria Ripoli; Nazzareno Capitanio; Massimo Zeviani; Sergio Papa
Journal:  J Biol Chem       Date:  2006-02-13       Impact factor: 5.157

7.  Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I).

Authors:  A Majander; M Finel; M Wikström
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

Review 8.  Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.

Authors:  William J Burke; Shu Wen Li; Hyung D Chung; David A Ruggiero; Bruce S Kristal; Eugene M Johnson; Patricia Lampe; Vijaya B Kumar; Mark Franko; Evelyn A Williams; Daniel S Zahm
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

Review 9.  Parkinson's disease: piecing together a genetic jigsaw.

Authors:  M C J Dekker; V Bonifati; C M van Duijn
Journal:  Brain       Date:  2003-05-21       Impact factor: 13.501

10.  Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

Authors:  V Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; M W Horstink; J A Maat-Kievit; C Sampaio; A Antonini; F Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; G Meco; B A Oostra
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

View more
  46 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Exposure to Mn/Zn ethylene-bis-dithiocarbamate and glyphosate pesticides leads to neurodegeneration in Caenorhabditis elegans.

Authors:  Rekek Negga; David A Rudd; Nathan S Davis; Amanda N Justice; Holly E Hatfield; Ana L Valente; Anthony S Fields; Vanessa A Fitsanakis
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

4.  Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.

Authors:  Cynthia A Kelm-Nelson; Sharon A Stevenson; Michelle R Ciucci
Journal:  Neurosci Lett       Date:  2016-04-04       Impact factor: 3.046

Review 5.  Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism.

Authors:  Sergio Papa; Anna Maria Sardanelli; Nazzareno Capitanio; Claudia Piccoli
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

6.  Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.

Authors:  Diogo Martins Branco; Daniela M Arduino; A Raquel Esteves; Diana F F Silva; Sandra M Cardoso; Catarina Resende Oliveira
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

Review 7.  The mitochondrial kinase PINK1, stress response and Parkinson's disease.

Authors:  Marina Jendrach; Suzana Gispert; Filomena Ricciardi; Michael Klinkenberg; Rudolf Schemm; Georg Auburger
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

Review 8.  The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics.

Authors:  Kelly Jean Thomas; Mark R Cookson
Journal:  Int J Biochem Cell Biol       Date:  2009-03-05       Impact factor: 5.085

9.  Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo.

Authors:  Jina Yun; Joseph H Cao; Mark W Dodson; Ira E Clark; Pankaj Kapahi; Ruhena B Chowdhury; Ming Guo
Journal:  J Neurosci       Date:  2008-12-31       Impact factor: 6.167

10.  PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.

Authors:  Wencheng Liu; Cristofol Vives-Bauza; Rebeca Acín-Peréz-; Ai Yamamoto; Yingcai Tan; Yanping Li; Jordi Magrané; Mihaela A Stavarache; Sebastian Shaffer; Simon Chang; Michael G Kaplitt; Xin-Yun Huang; M Flint Beal; Giovanni Manfredi; Chenjian Li
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.